Alexis Investment Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-50
Closed -$5.26K 78
2025
Q4
$5.26K Hold
50
﹤0.01% 86
2025
Q3
$4.2K Buy
+50
New +$4.12K ﹤0.01% 85
2025
Q1
Sell
-50
Closed -$4.97K 74
2024
Q4
$4.97K Buy
+50
New +$5.16K ﹤0.01% 74

Other funds holding MRK

Alexis Investment Partners's MRK Position: Q1 2026 in Review

Alexis Investment Partners sold out of Merck (MRK) in Q1 2026, closing a stake of 50 shares — an estimated $5.26K sold.

Alexis Investment Partners first reported a position in MRK in Q4 2024 and held it in 3 quarters. The position peaked at $5.26K in Q4 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Alexis Investment Partners reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Alexis Investment Partners sold 50 Merck shares in Q1 2026, an estimated $5.26K.
  • Alexis Investment Partners first reported a position in Merck in Q4 2024 and held it in 3 quarters.
  • Alexis Investment Partners's Merck position peaked at $5.26K in Q4 2025.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Alexis Investment Partners's 13F filing for Q1 2026, filed 24 Apr 2026.